Breaking News Instant updates and real-time market news.

BHC

Bausch Health

$21.08

0.17 (0.81%)

11:08
10/15/19
10/15
11:08
10/15/19
11:08

Bausch jumps 4% to $21.71 after Citron puts $40 target on shares

Andrew Left's Citron Research believes Bausch Health's quarterly results on November 4 "will force Wall St. to finally take notice" of the company's "pivot to offense." Once "this is considered along with the acknowledgment of the recent M&A spree in pharma, even David Maris will have to admit that BHC is on its way to $40," Citron said in a report posted on its website. The firm, best known for its short selling ideas, adds, "The new Bausch Health is not Valeant and investors have an opportunity to buy a well diversified pharmaceutical company with durable products and a healthy pipeline under a world-class management team that has proven their honesty and dedication." Shares of Bausch Health are up 4%, or 75c, to $21.66 in late morning trading. Citron put a $40 price target on the stock. Reference Link

  • 04

    Nov

BHC Bausch Health
$21.08

0.17 (0.81%)

09/11/19
GUGG
09/11/19
INITIATION
Target $30
GUGG
Buy
Bausch Health initiated with a Buy at Guggenheim
Guggenheim analyst Dana Flanders started Bausch Health with a Buy rating and $30 price target.
09/11/19
GUGG
09/11/19
INITIATION
GUGG
Buy
Bausch Health initiated with a Buy at Guggenheim
Guggenheim analyst Dana Flanders initiated Bausch Health with a Buy rating and a $30 price target, citing the company's strong execution and the durability of its businessses. Flanders believes Bausch will lower its $27B in debt over the next few years, which "should translate to a double-digit compounded equity return for shareholders."
09/17/19
WELS
09/17/19
NO CHANGE
WELS
Underperform
Wells says two of Bausch's 'Significant Seven' not on UnitedHealth benefit list
Wells Fargo analyst David Maris noted that United Healthcare (UNH) released its Pharmacy Benefit Coverage update, which shows that as of January 2020 it is excluding Bausch Health's (BHC) Bryhali, which he said is one of the company's "Significant Seven" focus products. Another of the Significant Seven, Siliq, will no longer be covered under UnitedHealth's pharmacy benefit plans, said Maris. Two other Significant Seven members - Vyzulta and Relistor - are listed as required step therapy and needing a prior authorization, respectively, Maris added. The analyst, who thinks Bausch Health's pipeline and recently approved products are "unimpressive," keeps an Underperform rating on the stock. Reference Link
10/03/19
PIPR
10/03/19
NO CHANGE
Target $29
PIPR
Overweight
Bausch unlikely to face generic Xifaxan before 2028, says Piper Jaffray
Piper Jaffray analyst David Amsellem says he would not be worried that a generic Xifaxan entrant will emerge prior to the January 2028 launch date outlined in Bausch Health Companies' (BHC) settlement with Teva (TEVA) on its generic filing. The analyst highlights the "relatively complex nature" of Xifaxan and Bausch's "fairly deep intellectual property estate." As such, he continues to believe that visibility into a "durable" EBITDA for Bausch Health is high, with a longer-term annual growth "reaching at least the high single digits." He reiterates an Overweight rating on the shares with a $29 price target.

TODAY'S FREE FLY STORIES

05:45
11/12/19
11/12
05:45
11/12/19
05:45
General news
NFIB Small Business Optimism Index level to be reported at 06:00 »

October NFIB Small…

ALB

Albemarle

$67.72

-0.29 (-0.43%)

05:37
11/12/19
11/12
05:37
11/12/19
05:37
Downgrade
Albemarle rating change  »

Albemarle downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 12

    Dec

CBMG

Cellular Biomedicine

$17.86

0.11 (0.62%)

05:36
11/12/19
11/12
05:36
11/12/19
05:36
Downgrade
Cellular Biomedicine rating change  »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNIRF

Senior plc

$0.00

(0.00%)

05:36
11/12/19
11/12
05:36
11/12/19
05:36
Downgrade
Senior plc rating change  »

Senior plc downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SOLVY

Solvay

$0.00

(0.00%)

05:34
11/12/19
11/12
05:34
11/12/19
05:34
Upgrade
Solvay rating change  »

Solvay upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

BOX

Box

$16.45

-0.495 (-2.92%)

05:32
11/12/19
11/12
05:32
11/12/19
05:32
Downgrade
Box rating change  »

Box downgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

CTVA

Corteva

$26.74

0.54 (2.06%)

05:30
11/12/19
11/12
05:30
11/12/19
05:30
Initiation
Corteva initiated  »

Corteva initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

IFJPY

Informa

$0.00

(0.00%)

05:30
11/12/19
11/12
05:30
11/12/19
05:30
Upgrade
Informa rating change  »

Informa upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPKFF

LPKF Laser & Electronics

$0.00

(0.00%)

05:29
11/12/19
11/12
05:29
11/12/19
05:29
Downgrade
LPKF Laser & Electronics rating change  »

LPKF Laser &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETN

Eaton

$91.87

-0.35 (-0.38%)

05:28
11/12/19
11/12
05:28
11/12/19
05:28
Downgrade
Eaton rating change  »

Eaton downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 19

    Nov

  • 19

    Nov

COVTY

Covestro

$0.00

(0.00%)

05:27
11/12/19
11/12
05:27
11/12/19
05:27
Downgrade
Covestro rating change  »

Covestro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPRUY

Kering

$0.00

(0.00%)

05:27
11/12/19
11/12
05:27
11/12/19
05:27
Upgrade
Kering rating change  »

Kering upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$16.11

-0.1 (-0.62%)

05:26
11/12/19
11/12
05:26
11/12/19
05:26
Upgrade
Fiat Chrysler rating change  »

Fiat Chrysler upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PUGOY

Peugeot

$0.00

(0.00%)

05:26
11/12/19
11/12
05:26
11/12/19
05:26
Upgrade
Peugeot rating change  »

Peugeot upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAVS

Ageagle Aerial Systems

$0.42

0.0385 (10.13%)

05:25
11/12/19
11/12
05:25
11/12/19
05:25
Conference/Events
Ageagle Aerial Systems to host business news update conference call »

Conference call to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

NNGRY

NN Group

$0.00

(0.00%)

05:25
11/12/19
11/12
05:25
11/12/19
05:25
Downgrade
NN Group rating change  »

NN Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERJ

Embraer

$17.10

-0.22 (-1.27%)

05:23
11/12/19
11/12
05:23
11/12/19
05:23
Earnings
Embraer backs FY20 revenue view of $2.5B-$2.8B »

May not compare to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

PRBZF

Premium Brands

$0.00

(0.00%)

05:22
11/12/19
11/12
05:22
11/12/19
05:22
Downgrade
Premium Brands rating change  »

Premium Brands downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERJ

Embraer

$17.10

-0.22 (-1.27%)

05:21
11/12/19
11/12
05:21
11/12/19
05:21
Earnings
Embraer backs FY19 revenue guidance of $5.3M-$5.7M, consensus $5.37M »

Embraer reaffirms…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

OZMLF

Oz Minerals

$0.00

(0.00%)

05:21
11/12/19
11/12
05:21
11/12/19
05:21
Downgrade
Oz Minerals rating change  »

Oz Minerals downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SESN

Sesen Bio

$1.14

(0.00%)

05:20
11/12/19
11/12
05:20
11/12/19
05:20
Conference/Events
Sesen Bio to host business news update conference call »

Conference call to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ERJ

Embraer

$17.10

-0.22 (-1.27%)

05:19
11/12/19
11/12
05:19
11/12/19
05:19
Earnings
Embraer reports Q3 EPS (26c), consensus (9c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

AAXN

Axon

$64.41

-0.95 (-1.45%)

05:18
11/12/19
11/12
05:18
11/12/19
05:18
Recommendations
Axon analyst commentary  »

Axon price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

INFO

IHS Markit

$68.90

-0.72 (-1.03%)

05:18
11/12/19
11/12
05:18
11/12/19
05:18
Conference/Events
IHS Markit to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

PLNT

Planet Fitness

$67.73

-0.7 (-1.02%)

05:16
11/12/19
11/12
05:16
11/12/19
05:16
Recommendations
Planet Fitness analyst commentary  »

Planet Fitness price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.